Cell therapy for ARDS and sepsis

Chairs: Paolo Pelosi (Milano, Italy), Antonio Artigas (Sabadell, Spain)
Aims: After this session the attendees will understand the basic mechanisms and the roles of cell therapy in preclinical models of lung injury and severe sepsis and how to lead and implement first-in-human trials of lung cell therapy.
Type II pneumocyte transplantation in ARDS
Raquel Guillamat-Prats (Barcelona, Spain)
WebcastSlide presentation
WebcastSlide presentation